For Healthcare Professionals With Medical QuestionsFind Your Field Medical Director
October 13, 2023
– These awards mark Dermavant’s eighth recognition by the organizations for its commitment to providing an inclusive and collaborative workplace culture. –
LONG BEACH, Calif., and BASEL, Switzerland, October 13, 2023 – Dermavant Sciences, a biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today announced that the company has been named one of 2023’s Best Workplaces for Millennials™, Best Medium Workplaces™ and Best Workplaces in Biopharma™ by Fortune magazine and Great Place to Work® — Dermavant’s eighth recognition by the organizations.
“At Dermavant, we pour our values of Heart, Mind, and Soul into everything we do,” said Todd Zavodnick, the Chief Executive Officer. “Being recognized by an organization of Fortune’s esteem on multiple occasions is a testament to the talented and passionate people that make up Dermavant and our commitment to cultivating a highly collaborative, innovative, and entrepreneurial culture. I am incredibly proud of the passion and talent of our team and what they have accomplished for people living with chronic skin conditions.”
To be listed in the Fortune Best Workplaces for Millennials™ List, companies had to be Great Place To Work Certified™ and have at least 50 millennial employees in the U.S. At a time when nearly half of U.S. employees are considering leaving their jobs, Dermavant has found the key to attracting millennials, the largest generation in the U.S. workforce, making up nearly 1/3 of their company.
“The workplace experience of millennials says a lot about your organization,” says Michael C. Bush, CEO of Great Place To Work®. “These workers are looking for authentic leadership, meaningful work, and a healthy work environment — and they show loyalty to those who can deliver.”
To determine the Fortune Best Medium Workplaces and Best Workplaces in Biopharma lists, Great Place to Work® analyzed survey responses from more than 30,000 employees from Great Place to Work-Certified™ companies. In surveys, 96% of Dermavant employees said it is a great place to work, compared to 57% of employees at a typical U.S.-based company.1
“At Dermavant, we pride ourselves on cultivating a highly collaborative, supportive, and honest culture to help foster workplace innovation,” said Bryan Gillespie, Vice President of Human Resources at Dermavant. “We maintain an open-door policy at all levels to ensure every employee is seen and valued.”
These awards come shortly after Dermavant was named one of the “100 Best Places to Work in Los Angeles” by the Los Angeles Business Journal for the fourth consecutive year, earning the number 19 spot on the 2023 Large-Sized Companies list.
Dermavant Sciences, a subsidiary of Roivant Sciences, is a biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology. Dermavant’s focus is to develop therapies that have the potential to address high unmet medical needs while driving greater efficiency in research and clinical development. The company’s medical dermatology pipeline includes commercialized, late-stage and earlier-development product candidates that target specific unmet needs in two of the largest growing immuno-dermatology markets, plaque psoriasis and atopic dermatitis, as well as other immunological and inflammatory diseases. Dermavant is marketing tapinarof for the topical treatment of plaque psoriasis in adults. Dermavant is also developing tapinarof for the treatment of atopic dermatitis in adults and children and released topline results from its Phase 3 clinical trials in the first half of calendar year 2023. Dermavant’s pipeline includes DMVT-506, a next generation aryl hydrocarbon receptor (AhR) agonist under development as a potential differentiated treatment option for immunological and inflammatory diseases with multiple potential routes of administration. For more information, please visit www.dermavant.com and follow us on Twitter (@dermavant) and LinkedIn (Dermavant Sciences).
About the Fortune Best Workplaces for Millennials List
Great Place To Work selected the Fortune Best Workplaces for Millennials List by surveying companies employing 7.5 million people in the U.S. with 1.3 million confidential survey responses received. Of those, nearly 500,000 responses were received from millennials at companies eligible for the list and these rankings are based on that feedback. Read the full methodology.
About the Fortune Best Medium Workplaces List
Great Place To Work selected the Fortune Best Medium Workplaces List by surveying companies employing 7.5 million people in the U.S. with 1.3 million confidential responses received. Of those, more than 210,000 responses were received from employees at companies eligible for the Best Medium Workplaces list and this ranking is based on that feedback. Company scores are derived from 60 employee experience questions within the Great Place To Work Trust Index™ Survey. Read the full methodology.
About the Fortune Best Workplaces in BioPharma List
Great Place To Work selected the 2023 Fortune Best Workplaces in BioPharma by gathering and analyzing confidential survey responses from more than 29,000 employees at Great Place To Work Certified organizations in the biopharma industry. Company rankings are derived from 60 employee experience questions within the Great Place To Work Trust Index™ Survey. Great Place To Work determines its lists using its proprietary For All Methodology to evaluate and certify thousands of organizations in America’s largest ongoing annual workforce study. In the last year, 1.3 million survey responses were received, representing the work experiences of 7.5 million employees. Read the full methodology.
About Great Place To Work
As the global authority on workplace culture, Great Place To Work brings 30 years of groundbreaking research and data to help every place become a great place to work for all. Their proprietary platform and For All™ Model help companies evaluate the experience of every employee, with exemplary workplaces becoming Great Place To Work Certified™ or receiving recognition on a coveted Best Workplaces™ List.
The Fortune mission is to change the world by making business better. We achieve that by providing trusted information, telling great stories, and building world-class communities. We measure performance by rigorous benchmarks. And we hold companies accountable. Our goal is to make Fortune a force for good through its second century and beyond. For more information, visit www.fortune.com.
© 2023 Dermavant Sciences, Inc. All Rights Reserved. All trademarks are the property of their respective owners.
# # #
1 Great Place to Work® 2021 Global Employee Engagement Study. Available at: https://www.greatplacetowork.com/resources/blog/global-employee-engagement-benchmark-study. Accessed June 2023.